BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26043413)

  • 1. Risks of nonadherence to hormone therapy in Asian women with breast cancer.
    Hsieh KP; Chen LC; Cheung KL; Yang YH
    Kaohsiung J Med Sci; 2015 Jun; 31(6):328-34. PubMed ID: 26043413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonadherence to Medications for Chronic Conditions and Nonadherence to Adjuvant Hormonal Therapy in Women With Breast Cancer.
    Neugut AI; Zhong X; Wright JD; Accordino M; Yang J; Hershman DL
    JAMA Oncol; 2016 Oct; 2(10):1326-1332. PubMed ID: 27281650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients.
    Hershman DL; Kushi LH; Shao T; Buono D; Kershenbaum A; Tsai WY; Fehrenbacher L; Gomez SL; Miles S; Neugut AI
    J Clin Oncol; 2010 Sep; 28(27):4120-8. PubMed ID: 20585090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer.
    Neugut AI; Subar M; Wilde ET; Stratton S; Brouse CH; Hillyer GC; Grann VR; Hershman DL
    J Clin Oncol; 2011 Jun; 29(18):2534-42. PubMed ID: 21606426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A competing risk analysis of hormone therapy interruption in Asian women with breast cancer.
    Hsieh KP; Chen LC; Cheung KL; Yang YH
    Pharmacoepidemiol Drug Saf; 2015 Mar; 24(3):301-9. PubMed ID: 25504903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical Estrogen Prescription Fill Rates for Women With a History of Breast Cancer Who Are Taking Hormone Therapy.
    Huntley JH; Richter LA; Blackford AL; Aliu O; Pollack CE
    Obstet Gynecol; 2018 Nov; 132(5):1137-1142. PubMed ID: 30303924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interruption and non-adherence to long-term adjuvant hormone therapy is associated with adverse survival outcome of breast cancer women--an Asian population-based study.
    Hsieh KP; Chen LC; Cheung KL; Chang CS; Yang YH
    PLoS One; 2014; 9(2):e87027. PubMed ID: 24586261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine Therapy Nonadherence and Discontinuation in Black and White Women.
    Wheeler SB; Spencer J; Pinheiro LC; Murphy CC; Earp JA; Carey L; Olshan A; Tse CK; Bell ME; Weinberger M; Reeder-Hayes KE
    J Natl Cancer Inst; 2019 May; 111(5):498-508. PubMed ID: 30239824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant therapy use among Appalachian breast cancer survivors.
    Tan X; Marshall VD; Anderson RT; Donohoe J; Camacho F; Balkrishnan R
    Medicine (Baltimore); 2015 Jul; 94(26):e1071. PubMed ID: 26131828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer.
    Nekhlyudov L; Li L; Ross-Degnan D; Wagner AK
    Breast Cancer Res Treat; 2011 Nov; 130(2):681-9. PubMed ID: 21842245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of subgroups of early breast cancer patients at high risk of nonadherence to adjuvant hormone therapy: results of an Italian survey.
    Tinari N; Fanizza C; Romero M; Gambale E; Moscetti L; Vaccaro A; Seminara P; Longo F; Gori S; Vici P; Gamucci T; Mauri M; Laudadio L; Nuzzo A; Fabbri MA; Fattoruso SI; Mazzilli L; Grassadonia A; Cianchetti E; Natoli C
    Clin Breast Cancer; 2015 Apr; 15(2):e131-7. PubMed ID: 25454738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer.
    Hershman DL; Shao T; Kushi LH; Buono D; Tsai WY; Fehrenbacher L; Kwan M; Gomez SL; Neugut AI
    Breast Cancer Res Treat; 2011 Apr; 126(2):529-37. PubMed ID: 20803066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Detection of Nonadherence to Adjuvant Tamoxifen and Breast Cancer Recurrence Risk.
    Pistilli B; Paci A; Ferreira AR; Di Meglio A; Poinsignon V; Bardet A; Menvielle G; Dumas A; Pinto S; Dauchy S; Fasse L; Cottu PH; Lerebours F; Coutant C; Lesur A; Tredan O; Soulie P; Vanlemmens L; Jouannaud C; Levy C; Everhard S; Arveux P; Martin AL; Dima A; Lin NU; Partridge AH; Delaloge S; Michiels S; André F; Vaz-Luis I
    J Clin Oncol; 2020 Aug; 38(24):2762-2772. PubMed ID: 32568632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to adjuvant endocrine therapy in estrogen receptor-positive breast cancer patients with regular follow-up.
    Simon R; Latreille J; Matte C; Desjardins P; Bergeron E
    Can J Surg; 2014 Feb; 57(1):26-32. PubMed ID: 24461223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Endocrine Therapy Agent, Race/Ethnicity, and Time on Therapy Predict Adherence in Breast Cancer Patients in a Large Academic Institution.
    Hwang GS; Paranjpe R; Opsomer C; Lu K; Abajue U; Abughosh S; Zaghloul H; Trivedi MV
    Clin Breast Cancer; 2020 Dec; 20(6):520-526. PubMed ID: 32669209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-Year Adjuvant Endocrine Therapy Adherence Trajectories Among Women With Breast Cancer: A Nationwide French Study Using Administrative Data.
    Lailler G; Memoli V; Le Bihan Benjamin C; Ben Diane MK; Lauzier S; Mancini J; Bousquet PJ; Bouhnik AD
    Clin Breast Cancer; 2021 Aug; 21(4):e415-e426. PubMed ID: 33745868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer.
    Ziller V; Kalder M; Albert US; Holzhauer W; Ziller M; Wagner U; Hadji P
    Ann Oncol; 2009 Mar; 20(3):431-6. PubMed ID: 19150950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of endocrine therapy in a national cohort of early stage HER2-positive breast cancer patients.
    Tervonen HE; Daniels B; Tang M; Preen DB; Pearson SA
    Pharmacoepidemiol Drug Saf; 2019 Jun; 28(6):812-820. PubMed ID: 30861596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonadherent behaviors among young women on adjuvant endocrine therapy for breast cancer.
    Wassermann J; Gelber SI; Rosenberg SM; Ruddy KJ; Tamimi RM; Schapira L; Borges VF; Come SE; Meyer ME; Partridge AH
    Cancer; 2019 Sep; 125(18):3266-3274. PubMed ID: 31120571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer.
    Partridge AH; Wang PS; Winer EP; Avorn J
    J Clin Oncol; 2003 Feb; 21(4):602-6. PubMed ID: 12586795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.